Sinaiko A R, Mirkin B L
Am J Nephrol. 1982;2(5):261-8. doi: 10.1159/000166657.
The diagnostic accuracy of renal vein renin (RVR) analyses was evaluated in 63 hypertensive patients treated with sodium depletion and/or hydralazine prior to selective renal vein sampling. A positive RVR study (i.e., lateralization of RVR) was defined as a ratio greater than or equal to 1.5 when RVR from the kidney with renal artery stenosis was compared to RVR from the contralateral kidney. Approximately 40% of patients with essential hypertension had positive RVR studies. Among patients with renal artery stenosis, surgical outcome was correctly predicted in 5 of 8 patients (63%) treated with sodium depletion, whereas outcome was accurately predicted in 11 of 12 patients (92%) treated with hydralazine. These observations demonstrate that a high percentage of patients with essential hypertension have positive RVR studies despite arteriographically normal renal vasculature. Results obtained in patients with renal artery stenosis suggest that stimulation of renin secretion by hydralazine may be of particular advantage prior to renal vein sampling. However, additional data are required to confirm whether activation of specific mechanisms for renin release improves the reliability of the RVR test.
在63例高血压患者中评估了肾静脉肾素(RVR)分析的诊断准确性,这些患者在进行选择性肾静脉采样前接受了限钠和/或肼屈嗪治疗。当将肾动脉狭窄侧肾脏的RVR与对侧肾脏的RVR进行比较时,RVR研究阳性(即RVR侧化)定义为比值大于或等于1.5。约40%的原发性高血压患者RVR研究呈阳性。在肾动脉狭窄患者中,8例接受限钠治疗的患者中有5例(63%)手术结果得到正确预测,而12例接受肼屈嗪治疗的患者中有11例(92%)结果得到准确预测。这些观察结果表明,尽管肾血管造影显示正常,但仍有相当比例的原发性高血压患者RVR研究呈阳性。肾动脉狭窄患者的结果提示,在肾静脉采样前,肼屈嗪刺激肾素分泌可能具有特别的优势。然而,需要更多数据来证实肾素释放的特定机制激活是否能提高RVR检测的可靠性。